PALM BEACH COUNTY MAYOR MACK BERNARD JOINS NATIONAL ECONOMIC MOBILITY LEADERSHIP NETWORK

Palm Beach County Mayor Mack Bernard

Mayor Bernard to address economic mobility by engaging on workforce opportunities, poverty, education & more to create local solutions for Palm Beach County

PALM BEACH COUNTY, FLORIDA, UNITED STATES, July 31, 2019 /EINPresswire.com/ — Mayor Mack Bernard of Palm Beach County, Florida, announced that he is among the 20 leaders from across the nation who have been invited to participate in the National Economic Mobility Leadership Network, a new program that brings together diverse and bipartisan county leaders from across the country to explore the role counties can play to positively affect economic mobility. The network is run by the National Association of Counties (NACo) and is funded by the Bill & Melinda Gates Foundation.

“It's an honor to be a part of this important initiative and I look forward to working with leaders from across the country on reviewing what innovative ideas and solutions can create economic opportunities for Palm Beach County’s families and businesses,” said Mayor Bernard. “The National Economic Mobility Leadership Network is another way Palm Beach County is taking the initiative to increase economic mobility, dismantle stigmas around poverty, and develop local solutions that drive economic mobility upward. I have a bold vision for Palm Beach County’s future and remain committed to addressing economic inequality and creating opportunities for our entire community to succeed.”

The National Economic Mobility Leadership Network will travel to three counties that have made concerted efforts and demonstrated measurable success in addressing economic mobility in their counties. Throughout the two-day convenings, county leaders and experts will engage on a range of topics including: workforce development and opportunities; generational poverty; affordable housing; access to financial services; educational opportunities and attainment; transportation access; health care services and access; technology and information access; criminal justice reform; geographic mobility and data collection, use, and sharing. The leaders will also visit sites that demonstrate the program and meet local leaders (within the county and outside) and those impacted by these programs and services.

Their first visit will be to Multnomah County, Oregon from July 30th to August 1st. After that, the cohort will visit Hennepin County, Minnesota in September, and Garret County, Maryland in November.

For more information about Mayor Mack Bernard, visit his website here.

About NACo
NACo is the only national organization representing county governments in the United States. NACo assists America’s 3,069 counties—including the nearly 40,000 county elected officials and 3.6 million county employees that serve counties—in pursuing excellence in public service to create healthy, vibrant, and safe counties.

Wilneeda Emmanuel
Commission Administrative Assistant
+1 561-355-2207
email us here


Source: EIN Presswire

HOW ARE TARIFFS & TRADE BARRIERS IMPACTING THE FURNITURE BUSINESS?

USA Tariffs on Chinese Import

Custom l shape desk formaspace office

Custom Formaspace Office U-shaped desk features walnut worksurfaces with a perforated steel modesty panel.

wet lab workbenches

These Formaspace workbenches built for a titration lab at the American operations of a major Swiss-based conglomerate features gray epoxy Basix™ work worksurfaces with hanging steel cabinets and drawers, 7 flex monitor mounts, manual crank hydraulic heigh

Find out how increased tariffs on Chinese imports could change the future of the furniture manufacturing industry forever.

Take a look at the effect of tariffs on the furniture import/export business as well as their impact on the availability of raw materials used in the furniture making industry.”

— Formaspace

AUSTIN, TX, UNITED STATES, July 31, 2019 /EINPresswire.com/ — Threats of new trade tariffs have the potential to change the furniture industry, even at a company such as Formaspace that manufacture 100% of its furniture products here in the USA. We take a look at the effect of tariffs on the furniture import/export business as well as their impact on the availability of raw materials used in the furniture making industry.

Are we in a trade war?

That’s the billion dollar question that the stock market investors, businesses, and consumers are asking.

The stakes are high as the administration turns to the threat of tariffs as part of its ongoing negotiating strategy to sign new international trade agreements, which they believe are more favorable to American manufacturing and that safeguard American intellectual property (IP).

Actions threatened by Washington against one particular company, the Chinese multi-national electronics and communications giant Huawei, seem to have grabbed all the headlines in recent days – understandably so given the enormous consequences for tech companies, from Apple to Qualcomm, who are facing up to the prospect of having to unwind a truly global supply chain for computer chips and telecommunication components.

U.S. Trade Deficits In The Durable Manufactured Goods
But despite the importance of the electronics industry, it’s not the entire economy, at least not yet.

Given the seriousness of the current and proposed tariffs, we think it’s important to take a look at the balance of trade in durable manufactured goods, then drill down into the effects that tariffs will have on our corner the market: the furniture business.

Where do we stand at the moment with current U.S. trade deficits?

For durable manufactured goods, the picture is not great. Federal agencies report that in 2018, the US imported around $605 billion more durable manufactured goods than we exported. The trend has worsened over the last 5 years: the U.S. net trade deficit in durable manufactured goods has grown by 144% since 2014.

As you can see from the economic data shown in the chart above, we are currently running an account surplus in durable manufactured goods with Canada, Hong Kong, the Netherlands, Australia, and the United Arab Emirates, as well as many other countries shown in green on the map above.

At the other end of the scale are five countries – South Korea, Germany, Japan, Mexico, and China – with whom we have the largest net trading deficits in durable manufactured goods.

Imbalanced trade with China in durable manufactured goods poses a big problem for the US: In 2018, we bought $338 billion more durable manufactured goods from China than we were able to sell to back them – creating a trade deficit that is nearly 10 times the net surplus we have with our best customer, Canada.

The Threat Of Raising Section 301 Tariffs On Chinese Goods From 10% To 25%

The administration in Washington responded to the overseas trade deficit with China by instituting a 10% tariff on many Chinese imports under Section 301 of the Trade Act of 1974. (This was in addition to a tariff on steel and aluminum products, more on that later.)

Then on May 10, 2019, the office of the U.S. Trade Representative announced: “Earlier today, at the direction of the President, the United States increased the level of tariffs from 10 percent to 25 percent on approximately $200 billion worth of Chinese imports. The President also ordered us to begin the process of raising tariffs on essentially all remaining imports from China, which are valued at approximately $300 billion.”

How will this affect our corner of the market, the furniture business?

Fortunately for Formaspace, the direct effects will be minimal. As you probably know, we manufacture all our furniture here in the USA at our Austin, Texas factory headquarters – using locally-supplied raw materials, including domestic steel and wood products.

As a result, Formaspace won’t be directly affected by the new tariffs on imported goods and materials (with the exception of some hardware items, which do come from overseas); however, there may be some indirect effects from these tariffs over the coming months, such as the possibility of increased prices for domestic steel.

But what about other companies that import Chinese furniture products or depend on Chinese raw materials? They could be hit pretty hard.

How hard? Let’s first take a look at the trade balance for imports and exports of U.S. furniture products.

According to Federal trade statistics, the United States is currently running a nearly $40 billion deficit in the overall furniture and fixtures market. Once again, China is racking up the biggest trade deficit, it sold nearly $26 billion more furniture and fixtures to the US in 2018 than we sold back to them. The Chinese imbalance in furniture trade is relatively large compared to that of our other trading partners: e.g. China’s furniture trading deficit is five times larger than that of the next country on the list, Vietnam.

Long-term South African Expat Vlogger Serpentza Provides his Perspective on US-Chinese Trade Relations

What Are The Consequences Of Raising Section 301 Tariffs On Chinese Imported Furniture From 10% To 25%?

Read more…https://formaspace.com/articles/industrial/tariffs-trade-barriers-impacting-furniture-business/?utm_source=einpresswire&utm_medium=content&utm_campaign=article-052719

Mehmet Atesoglu
Formaspace
+5122792792
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Left or Right, Which Way? New book with choices for American Evangelical Christians

Book information

Following Jesus challenges for American Evangelical Christians

In this book the reader is encouraged to reflect, to ask and answer questions, while examining Jesus' life and ethical teachings”

— Mary Theresa Webb, PhD, author of Following Jesus in the Age of Trump

MAITLAND, FLORIDA, UNITED STATES, July 31, 2019 /EINPresswire.com/ — Xulon Press

Website: followingjesusintrumpage.com

MAITLAND, FL—Dr. Mary Theresa Webb calls all Christians to follow Christ’s example, regardless of political party, in Following Jesus in the Age of Trump ($17.49, paperback, 9781545664285; $8.99, e-book, 9781545664292). She shares teachings from history and the Bible, particularly the Beatitudes that provide a compass for Christians who desire to walk Jesus’ narrow way.

Whether readers agree or disagree with a current political party, www.linkedin.com/in/mary-theresa-webb-706965ab/ and 2000 years of Christian history stand and will not change.

“In this book the reader is encouraged to reflect, to ask and answer questions, while examining Jesus' life and ethical teachings,” says author Webb.

Dr. Mary Theresa Webb is an evangelical Christian who holds a Masters in Education, a certificate as a Pastoral Counselor with a degree in biblical and ethical studies from the Anglican Trinity School for Ministry, and a doctorate in Addiction Intervention. She is also the author of: Memories and Miracles: Stories and Reflections on Russians from an American Missionary; Who's Calling? Ministry Discernment, Disasters, Restoration; Thaddeus Stevens: An Inconvenient Hero; Tree of Life, Addiction Recovery and God’s Grace; and Healing Bruised Souls: A Church Training Manual.

Xulon Press, a division of Salem Media Group, is the world’s largest Christian publisher, with more than 12,000 titles published to date. Following Jesus in the Age of Trump is available online through xulonpress.com/bookstore, amazon.com, and barnesandnoble.com.

Author is available for radio and TV interviews and church programs.

Mary Theresa Webb
Books and Programs
+1 717-464-0962
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Axne, Loebsack, and Finkenauer Work to End Horse Abuse, Steve King Votes to Allow Cruelty to Continue

Soring

Example of soring that enforcement of the Horse Protection Act would prevent

No animal should ever be abused for entertainment, and I was proud to support the PAST Act to protect horses and hold bad actors accountable.”

— U.S. Rep. Cindy Axne

WASHINGTON, DC, USA, July 31, 2019 /EINPresswire.com/ — On Thursday, the U.S. House of Representatives passed the Prevent All Soring Tactics (PAST) Act, H.R. 693, by a vote of 333 to 96. U.S. Reps. Cindy Axne, David Loebsack, and Abby Finkenauer – all cosponsors of the measure – voted in support of the bill. U.S. Rep. Steve King, well known for his extremist, anti-animal stances, was the only Iowa representative to vote against the bill.

The PAST Act seeks to strengthen the Horse Protection Act and end the torturous, painful practice of soring Tennessee Walking, Racking, and Spotted Saddle Horses. Soring, the intentional infliction of pain to horses’ front limbs by applying caustic chemicals such as mustard oil or kerosene or inserting sharp objects into the horses’ hooves to create an exaggerated gait known as the “Big Lick,” has plagued the equine world for six decades.

"Horse soring is a cruel and painful practice that has gone on for far too long," said U.S. Representative Cindy Axne (D-IA-1)."No animal should ever be abused for entertainment, and I was proud to support the PAST Act to protect horses and hold bad actors accountable.”

“We applaud Reps. Axne, Loebsack, and Finkenauer for their key role in overwhelmingly passing the PAST Act to end this barbaric and indefensible practice that has marred the horse show world for decades,” said Marty Irby, executive director at Animal Wellness Action and past president of the Tennessee Walking Horse Breeders’ & Exhibitors’ Association. “The landslide vote in support of the bill is a powerful signal to the Senate that it should saddle up and end this cruelty to horses once and for all.”

The PAST Act would ban the use of painful large stacked shoes and ankle chains and would also eliminate the existing system of self-regulation by the industry and toughen penalties for violators of the Horse Protection Act. It’s supported by Animal Wellness Action, the American Horse Council, American Veterinary Medical Association, American Association of Equine Practitioners, United States Equestrian Federation, National Sheriff’s Association, and the Veterinary Medical Associations from all 50 states.

The PAST Act has been blocked for years by a handful of well-placed lawmakers, but a new House rule triggering consideration of any measure that attracts 290 or more cosponsors brought the issue to the floor. PAST attracted 308 cosponsors, and was led by U.S. Reps. Kurt Schrader (D-OR) and Ted Yoho (R-FL), cochairs of the Congressional Veterinary Medicine Caucus, along with Reps. Steve Cohen (D-TN), Ron Estes (R-KS), Jan Schakowsky (D-IL), and Chris Collins (R-NY). The Senate companion is led by U.S. Sens. Mike Crapo (R-ID) and Mark Warner (D-VA) has garnered 40 cosponsors.

See what Members of Congress from across the nation have to say about the PAST Act by clicking here.

The Animal Wellness Foundation (Foundation) is a Los Angeles-based private charitable organization with a mission of helping animals by making veterinary care available to everyone with a pet, regardless of economic ability. We organize rescue efforts and medical services for dogs and cats in need and help homeless pets find a loving caregiver. We are advocates for getting veterinarians to the front lines of the animal welfare movement; promoting responsible pet ownership; and vaccinating animals against infectious diseases such as distemper. We also support policies that prevent animal cruelty and that alleviate suffering. We believe helping animals helps us all.

Animal Wellness Action (Action) is a Washington, D.C.-based 501(c)(4) organization with a mission of helping animals by promoting legal standards forbidding cruelty. We champion causes that alleviate the suffering of companion animals, farm animals, and wildlife. We advocate for policies to stop dogfighting and cockfighting and other forms of malicious cruelty and to confront factory farming and other systemic forms of animal exploitation. To prevent cruelty, we promote enacting good public policies and we work to enforce those policies. To enact good laws, we must elect good lawmakers, and that’s why we remind voters which candidates care about our issues and which ones don’t. We believe helping animals helps us all.

Marty Irby
ANIMAL WELLNESS ACTION
2028215686
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Watchdog: Multi-Million Fines Insufficient to Curb Abuse in For-Profit Behavioral Health Industry

Media reports on the UHS payment said the company “has been dogged by the DOJ investigation into false claims allegedly submitted by its behavioral health facilities.”

Media reports on the UHS payment said the company “has been dogged by the DOJ investigation into false claims allegedly submitted by its behavioral health facilities.”

CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections.

CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections.

The headquarters for CCHR Florida are located in downtown Clearwater.

The headquarters for CCHR Florida are located in downtown Clearwater.

The Florida chapter of CCHR is a non-profit mental health watchdog dedicated to the protection of children.

The Florida chapter of CCHR is a non-profit mental health watchdog dedicated to the protection of children.

Since 2015, CCHR has exposed alleged abuses in for-profit hospitals accused of abusing involuntarily commitment to detain patients for their insurance.

Patient abuses in the psychiatric industry require much stronger penalties than a few million dollars in fines. Increased safeguards should include jail penalties, where criminal violations found.”

— Jan Eastgate, president of CCHR International

CLEARWATER, FLORIDA, UNITED STATES, July 31, 2019 /EINPresswire.com/ — Universal Health Services (UHS), which owns a chain of for-profit psychiatric facilities in the U.S. and the United Kingdom, has agreed to pay $127 million to settle a U.S. Department of Justice (DOJ) civil probe into alleged fraud. The settlement is subject to approval. [1] But Citizens Commission on Human Rights (CCHR), a mental health watchdog, says the proposed settlement is insufficient to send an adequate warning to other for-profit behavioral facilities accused of patient abuse and healthcare fraud.

Media reports on the UHS payment said the company “has been dogged by the DOJ investigation into false claims allegedly submitted by its behavioral health facilities.”

For decades CCHR has investigated allegations of abuse and potential fraud in for-profit psychiatric facilities. Since 2015, over 18,000 official complaints have been filed with Federal and State authorities and legislators. A CCHR International report on the issue published in December 2018 highlighted how behavioral companies get billions of dollars in Medicaid and Medicare rebates, yet the “return” appears to be more patient abuse.

CCHR says allegations of sexual abuse of patients in the for-profit behavioral hospital industry are rife. Last year, UHS closed its Timberlawn psychiatric hospital in Texas in the wake of allegations that a 13-year-old girl was raped at the facility. [2]

Sequel Youth and Family Services is a privately-owned company that and operates in about 20 states.

Other allegations about Sequel facilities include:

• May 2019: Utah’s Department of Human Services threatened the license of a Sequel-owned facility over "understaffing” that had “negatively impacted the program's ability to address violence and sexual misconduct within the program.” In response, Sequel announced that it is closing the facility. [3]

• 2018: In Iowa, a youth advocacy group from Washington State stopped sending children to Sequel’s Clarienda Academy after concerns were raised about the use of restraints. [4]

• August 2017: A 37-year-old staff Clarienda staffer was accused of forcible sodomy and lascivious conduct with a minor. [5]

• 2016: A 40-year-old night staff member at Clarienda was arrested and charged with three felony sex charges regarding a 17-year-old student. The staffer pleaded guilty to sexual misconduct and was sentenced to ten years’ probation. [6]

• July 2017: Police arrested a youth counselor with Sequel TSI of Madison, Alabama, on charges that she engaged in sex with a student under 19 years of age. She was indicted in September 2018 for sex acts involving multiple students under the age of 19. [7]

• January 2018: A 38-year-old staffer at Northern Illinois Academy was charged with three counts of criminal sexual assault on an adolescent, over whom he held a position of trust or authority. The staffer pleaded guilty and was sentenced to 10 years in prison. [8]

• August 2018: A Lakeside Academy in Kansas staffer was arrested on three counts of unlawful sexual relations involving a juvenile. [9]

• 2012: A Sequel staffer from Red Rock Canyon School (RRCS) in St. George, Utah was arrested and charged with sexually abusing three male students. [10] The staffer pleaded guilty to felony forcible sexual abuse and was sentenced to 210 days in jail and 36 months supervised probation. [11]

Recent controversy over RRCS led to Sequel’s decision to close the facility. On April 28, 2019, a two-hour riot erupted at the facility, with police, medical and SWAT forced to respond. 25 students were injured, of which five were transported to the hospital for more serious treatment, including one student who required staples to close a gash on the back of his head. [12]

CCHR says it is placing attention on Florida, where Sequel owns 10 facilities, and, in St. Petersburg and surrounding areas, offers “Foster homes” to provide services for children with severe mental health disorders/behavioral problems. [13]

Since 2015, CCHR International and its Florida Chapter have investigated and exposed alleged abuses in for-profit behavioral hospitals that have been accused of abusing the state’s Baker Act to involuntarily commit patients and detained them for their insurance.

UHS has some 16 behavioral facilities in Florida and closed its National Deaf Academy in 2014 following scrutiny of abuses reported to police, including three alleging sexual abuse. [14]

Jan Eastgate, the group’s international president, said: “Patient abuses in the psychiatric-behavioral industry require much stronger penalties than a few million dollars in fines where systemic patient abuse and/or fraud are established. Increased safeguards should include jail penalties, where criminal violations found.”

CCHR says West Palm Beach County, Florida State Attorney Dave Aronberg’s comments last year mirrors their concerns: “This is an entire industry that's been corrupted by easy money. Unscrupulous actors have taken advantage of well-intended federal law and a lack of any good law at the state level, to profit off people at the lowest stages of their lives.” [15]

CCHR calls for anyone whose mother, wife, sister or father, brother, son, child or friend has been killed or damaged by psychiatric “treatment” to fill out this form. For more information visit www.cchrflorida.org or call 727-442-8820.

About CCHR: Initially established by the Church of Scientology and renowned psychiatrist Dr. Thomas Szasz in 1969, CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. L. Ron Hubbard, founder of Scientology, first brought psychiatric imprisonment to wide public notice: “Thousands and thousands are seized without process of law, every week, over the ‘free world’ tortured, castrated, killed. All in the name of ‘mental health,’” he wrote in March 1969.

Complete documentation of all statements can be found here: https://www.cchrflorida.org/multi-million-files-insufficient-to-curb-abuse-in-for-profit-behavioral-health-industry/

Diane Stein
Citizens Commission on Human Rights of Florida
+1 727-422-8820
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Who Commits More Healthcare Fraud and Abuse?


Source: EIN Presswire

Breast Cancer Market 2019 Global Analysis, Growth, Size, Share, Trends, Forecast to 2023

Breast Cancer -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023

PUNE, MAHARASHTRA, INDIA, July 31, 2019 /EINPresswire.com/ — Breast Cancer Industry

Description

Breast cancer' defines a malignant tumor that has developed from cells in the breast. Some breast cancers are called in situ as they are confined within the ducts (ductal carcinoma in situ or DCIS) or lobules (lobular carcinoma in situ or LCIS) where they originated. Although, less commonly, breast cancer can also instigate in the stromal tissues, which includes the fatty and fibrous connective tissues of the breast. In the early stages, breast cancer may not cause any symptoms. A lump may be too small to feel or to cause any unusual changes that could be noticed on own. Typically, an abnormal area shows up on a screening mammogram which leads to further testing. Several risk factors including smoking and alcohol consumption, exposure to estrogen, gender, age, family history and personal history are linked to the growth of breast cancer.

The global breast cancer market is likely to grow strongly in the coming years driven by rising healthcare expenditure, rising diabetic and obese population, increasing consumption of alcohol and tobacco and rising female population above 65 years of age. Key trends of the market includes rising development of PARP inhibitors, increasing adoption of minimally invasive procedures and rising awareness programs and research grants. However, growth of the market can be hindered by several factors including financial burden of breast cancer, drug development challenges in developing countries, long term side effects of drugs.

The report "Global Breast Cancer Market: Industry Analysis & Outlook (2018-2022)" by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the US, Europe and APAC regions along with the global market. The report profiles the key players of the market including Johnson & Johnson, AbbVie, AstraZeneca and Roche.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3111580-global-breast-cancer-market-industry-analysis-outlook-2018-2022

Table of Content

1. Introduction

1.1 Breast Cancer 
1.2 Types 
1.3 Stages 
1.4 Risk Factors 
1.4 Symptoms & Diagnosis 
1.5 Treatment

2. Global Breast Cancer Market

2.1 Global Breast Cancer Market by Value 
2.2 Global Breast Cancer Market Forecast by Value 
2.3 Global Breast Cancer Market by Region 
2.4 Global Breast Cancer Drug Development by Stages

3. Regional Breast Cancer Market Analysis

3.1 The U.S. 
3.1.1 The U.S. Breast Cancer Market by Value 
3.1.2 The U.S. Breast Cancer Market Forecast by Value 
3.1.3 The U.S. Breast Cancer Market by Addressable Population 
3.1.4 The U.S. Breast Cancer Market Forecast by Addressable Population 
3.1.5 The U.S. Breast Cancer Population by Age 
3.1.6 The US HER2+ Node Positive Breast Cancer Patients Volume 
3.1.7 The US HER2+ Node Negative Breast Cancer Patients Volume 
3.1.8 The US HER2+ Node Negative (High Risk) Breast Cancer Patients Volume

3.2 Europe 
3.2.1 EU5 Breast Cancer Market by Value 
3.2.2 EU5 Breast Cancer Market Forecast by Value 
3.2.3 Europe HER2+ Node Positive Breast Cancer Patients Volume 
3.2.4 Europe HER2+ Node Negative Breast Cancer Patients Volume 
3.2.5 Europe HER2+ Node Negative (High Risk) Breast Cancer Patients Volume

3.3 APAC 
3.3.1 APAC Breast Cancer Market by Value 
3.3.2 APAC Breast Cancer Market Forecast by Value 
3.3.3 APAC Breast Cancer Market by Countries 
3.3.4 Japan's Breast Cancer Market by Value 
3.3.5 Japan's Breast Cancer Market Forecast by Value 
3.3.6 China's Breast Cancer Market by Value 
3.3.7 China's Breast Cancer Market Forecast by Value 
3.3.8 Australia's Breast Cancer Market by Value 
3.3.9 Australia's Breast Cancer Market Forecast by Value

4. Market Dynamics

4.1 Growth Drivers 
4.1.1 Rising Consumption of Tobacco and Alcohol 
4.1.2 Increasing Global Diabetic Population 
4.1.3 Accelerating Obese Population 
4.1.4 Increasing Healthcare Expenditure Per Capita 
4.1.5 Rising Female Population Aged 65 Years & Above

4.2 Key Trends & Developments 
4.2.1 PARP Inhibitors under Development 
4.2.32Rising Adoption of Minimally Invasive Procedures 
4.2.3 Increasing Awareness Programs and Research Grants

4.3 Challenges 
4.3.1 Financial Burden of Breast Cancer 
4.3.2 Drug Development Challenges in Developing Countries 
4.3.3 Long Term Side Effects

Leave a Query @ https://www.wiseguyreports.com/enquiry/3111580-global-breast-cancer-market-industry-analysis-outlook-2018-2022

5. Competition

5.1 Global Market 
5.1.1 Revenue Comparison by Company 
5.1.2 R&D Expenditure Comparison by Company 
5.1.3 Market Cap Comparison by Company

6. Company Profiles

6.1 Johnson & Johnson 
6.1.1 Business Overview 
6.1.2 Financial Overview 
6.1.3 Business Strategies

6.2 AstraZeneca 
6.2.1 Business Overview 
6.2.2 Financial Overview 
6.2.3 Business Strategies

6.3 AbbVie Inc. 
6.3.1 Business Overview 
6.3.2 Financial Overview 
6.3.3 Business Strategies

6.4 Roche 
6.4.1 Business Overview 
6.4.2 Financial Overview 
6.4.3 Business Strategies

List of Charts

Breast Cancer by Types 
Stage Occurrence of Breast Cancer in Patients 
Global Breast Cancer Market by Value (2013-2017) 
Global Breast Cancer Market Forecast by Value (2018-2022) 
Global Breast Cancer Market by Region (2017) 
Global Breast Cancer Drug Development by Stages (2017) 
The U.S. Breast Cancer Market by Value (2013-2017) 
The U.S. Breast Cancer Market Forecast by Value (2018-2022) 
The U.S. Breast Cancer Market by Addressable Population (2013-2017) 
The U.S. Breast Cancer Market Forecast by Addressable Population (2018-2022) 
The U.S. Breast Cancer Population by Age & Type (2017) 
The U.S. HER2+ Node Positive Breast Cancer Patients Volume (2017-2022) 
The U.S. HER2+ Node Negative Breast Cancer Patients Volume (2017-2022) 
The U.S. HER2+ Node Negative (High Risk) Breast Cancer Patients Volume (2017-2022) 
EU5 Breast Cancer Market by Value (2013-2017) 
EU5 Breast Cancer Market Forecast by Value (2018-2022)

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3111580

Continued…

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}
["facebook", "twitter", "linkedin"]


Source: EIN Presswire

Specialty Pharmaceutical in US Market 2019: Global Analysis, Share, Trends, Application Analysis and Forecast To 2024

Specialty Pharmaceutical -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023

PUNE, MAHARASHTRA, INDIA, July 31, 2019 /EINPresswire.com/ — Specialty Pharmaceutical Industry

Description

The US pharmaceutical market is segregated into two types of drugs majorly i.e. traditional drugs and specialty drugs. Specialty drugs in recent times have gained a strong foothold in the US and are likely to experience robust growth in the coming years, with majority of the pharmaceutical companies heading their research and development initiatives towards these drugs.

Specialty drugs are basically meant for chronic and rare disease. Drugs in this category are very expensive and difficult to administer. Also, these drugs require proper management and special handling making them costly. Since, a large part of population in the US is ageing into diseases like cancer, and other deadly diseases, the demand for specialty drugs has skyrocketed in recent times.

The US specialty pharmaceutical market has changed over the span of five years with a lot of these drugs being in their final phase of development. The US specialty pharmaceutical market is likely to grow at staggering growth rate in the coming years majorly due to factors like ageing population of the US, improving life expectancy, rise in real net per capita medicine spending on specialty drugs, and high prevalence of chronic disease in the region.

The market is also undergoing some notable changes that have been covered in the report. The market growth is likely to be hindered by abandonment rate of specialty medicines and high R&D costs. The report offers an in-depth analysis of the “The US Specialty Pharmaceutical Market: Industry Analysis & Outlook (2017-2021)”. Major pharmaceutical companies that have been covered in the report include Celgene Corporation, Gilead Sciences Inc., Amgen Inc., and AbbVie Inc.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/2622780-the-us-specialty-pharmaceutical-market-industry-analysis-outlook-2017-2021

Table of Content

1. Market Overview

1.1 Introduction
1.2 Specialty Pharmaceuticals Vs Traditional Drugs
1.3 Application of Specialty Pharmaceuticals
1.4 Specialty Pharmacy Services
1.5 Specialty Product Distribution
1.6 Specialty Pharma Manufacturer Services
1.7 Value Proposition of Specialty Pharmacy

2. The US Pharmaceutical Market Analysis

2.1 The US Pharmaceutical Market by Value
2.2 The US Pharmaceutical Market Forecast by Value
2.3 The US Pharmaceutical Market by Segment
2.3.1 The US Pharmaceutical Market by Segment
2.3.2 The US Pharmaceutical Market by Segment Forecast
2.3.3 The US Traditional Pharmaceutical Market by Value
2.3.4 The US Traditional Pharmaceutical Market Forecast by Value
2.4 The US Pharmaceutical Market’s Demand Growth
2.5 The US Pharmaceutical Market’s Drug Approval by Segment
2.6 The US Pharmaceutical Market by Drugs

3. The US Specialty Pharmaceutical Market

3.1 The US Specialty Pharmaceutical Market by Value
3.2 The US Specialty Pharmaceutical Market Forecast by Value
3.3 The US Specialty Pharmaceutical Market by Drugs
3.4 The US Specialty Pharmaceutical- Prescription Volume
3.4.1 The US Specialty Medication Prescription Volume
3.4.2 The US Specialty Medication Prescription Volume Forecast
3.4.3 The US Specialty Medication Prescription Volume by Therapeutic Class
3.4.4 The US Specialty Medication Prescription Volume Forecast by Therapeutic Class

Leave a Query @ https://www.wiseguyreports.com/enquiry/2622780-the-us-specialty-pharmaceutical-market-industry-analysis-outlook-2017-2021

4. Market Dynamics

4.1 Growth Drivers
4.1.1 Rise in Ageing Population of the US
4.1.2 Improving Life Expectancy
4.1.3 Surge in Spending on Medicines
4.1.4 Escalating Per Capita Heath Expenditure in the US
4.1.5 Prevalence of Chronic Disease in the US

4.2 Trend and Opportunities
4.2.1 Technology Enabled Transformation
4.2.2 Growing Foothold of Oncology Segment
4.2.3 Specialty Pharmacy Mergers and Acquisitions

4.3 Challenges and Issues
4.3.1 High Cost of Drugs
4.3.2 Abandonment Rates for Branded Medicines
4.3.3 High R&D Costs

5. Competitive Landscape

5.1 The US Specialty Pharmaceutical Market
5.1.1 Revenue Comparison by Major Players
5.2 The US Specialty Pharmaceutical Market by Therapeutic Class
5.2.1 The US Specialty Inflammatory Conditions Market Share by Drugs
5.2.2 The US Specialty Oncology Market Share by Drugs
5.2.3 The US Specialty Multiple Sclerosis Market Share by Drugs
5.2.4 The US Specialty HIV Market Share by Drugs
5.2.5 The US Specialty Hepatitis C Market Share by Drugs
5.3 The US Specialty Drug Pharmacies Market Share
5.4 The US Specialty Product Distribution Market Share

6. Company Profiles

6.1 Gilead Sciences Inc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies

6.2 AbbVie Inc.
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies

6.3 Amgen Inc.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies

6.4 Celgene Corporation
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies

List of Charts

Flow of Products within the Specialty Pharmacy Channel
SP Benefits Model
The US Pharmaceutical Market by Value (2012-2016)
The US Pharmaceutical Market Forecast by Value (2017-2021)
The US Pharmaceutical Market by Segment (2016)
The US Pharmaceutical Market by Segment Forecast (2021)
The US Traditional Pharmaceutical Market by Value (2012-2016)
The US Traditional Pharmaceutical Market Forecast by Value (2017-2021)
The US Pharmaceutical Market’s Demand Growth by Segment (2012-2016)
The US Pharmaceutical Market’s Drug Approval by Segment (2016)
The US Specialty Pharmaceutical Market by Value (2012-2016)
The US Specialty Pharmaceutical Market Forecast by Value (2017-2021)
The US Specialty Medication Prescription Volume (2012-2016)
The US Specialty Medication Prescription Volume Forecast (2017-2021)

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2622780

Continued…

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Advanced Wound Care Market 2019: Global Analysis, Share, Trends, Application Analysis and Forecast To 2024

Advanced Wound Care -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024

PUNE, MAHARASHTRA, INDIA, July 31, 2019 /EINPresswire.com/ — Advanced Wound Care Industry

Description

A wound is any disruption of the normal structure and function of the skin and its architecture. It causes pain, prolonged hospital stays, chronic morbidity and can lead to loss of limb or life. Wound management seeks to prevent or treat wounds by ensuring that it is free of dead tissue matter, infection free and moist. The wounds can be classified as acute and chronic.

Advanced wound care products are used to treat more complex, chronic and acute wounds using technology to aid the healing process. This category generally includes film and foam dressings, hydrogels, alginates and hydrocolloids. Treating an acute or chronic wound with the appropriate dressing assists the body’s natural healing processes. Using the right wound care products can speed up this process by encouraging new tissue formation. The advanced wound care products are largely focused on keeping the wound hydrated to encourage healing.

The global wound care market is set to experience favourable growth driven by factors such as rising ageing population, increasing life expectancy, rising diabetic population, growing population with ulcer pressures and increasing awareness of advanced wound care products. Further, the scope of growth for this market will be broadened by favourable reimbursement policies, technological advancements, emerging middle class population and strong research and development efforts by companies. However, the growth of this market will be hindered by high cost of advanced wound care products and stringent regulatory approval process.

The report “Global Advanced Wound Care Market: Industry Analysis & Outlook (2018-2022)” analyses the development of this market, with focus on the U.S. and Rest of the World. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Molnlycke, Smith & Nephew, Coloplast and ConvaTec are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global wound care market along with the study of the regional markets.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3080301-global-advanced-wound-care-market-industry-analysis-outlook-2018-2022

Table of Content

1. Market Overview

1.1 Wounds
1.2 Wound Care
1.3 Advanced Wound Care

2. Global Wound Care Market

2.1 Global Wound Care Market Forecast by Value
2.2 Global Wound Care Market by Region
2.2.1 North America Wound Care Market Forecast by Value
2.2.2 Europe Wound Care Market Forecast by Value
2.2.3 ROW Wound Care Market Forecast by Value
2.3 Global Wound Care Market by Segment
2.3.1 Surgical Wound Care Market Forecast by Value
2.3.2 Basic Wound Care Market Forecast by Value

3. Global Advanced Wound Care Market

3.1 Global Advanced Wound Care Market by Value
3.2 Global Advanced Wound Care Market Forecast by Value
3.3 Global Advanced Wound Care Market by Region
3.4 Global Advanced Wound Care Market by Segment
3.4.1 Global Advanced Wound Care Product Market by Value
3.4.2 Global Advanced Wound Care Product Market Forecast by Value
3.4.3 Global Advanced Wound Care Product Market by Region
3.4.4 Global Advanced Wound Care Product Market by Segment
3.4.5 Global Foam Market by Value
3.4.6 Global Foam Market Forecast by Value
3.4.7 Global Silver/Anti-Microbial Market by Value
3.4.8 Global Silver/Anti-Microbial Market Forecast by Value
3.4.9 Global Advanced Wound Care NPWT Devices Market by Value
3.4.10 Global Advanced Wound Care NPWT Devices Market Forecast by Value
3.4.11 Global Advanced Wound Care NPWT Devices Market by Region
3.4.12 Global Advanced Wound Care NPWT Devices Market by Segment

4. Regional Advanced Wound Care Market

4.1 The U.S.
4.1.1 The U.S. Advanced Wound Care Market by Value
4.1.2 The U.S. Advanced Wound Care Market Forecast by Value
4.1.3 The U.S. Advanced Wound Care Product Market by Value
4.1.4 The U.S. Advanced Wound Care Product Market Forecast by Value
4.1.5 The U.S. Advanced Wound Care NPWT Devices Market by Value
4.1.6 The U.S. Wound NPWT Devices Market Forecast by Value

4.2 ROW
4.2.1 ROW Advanced Wound Care Market by Value
4.2.2 ROW Advanced Wound Care Market Forecast by Value
4.2.3 ROW Advanced Wound Care Product Market by Value
4.2.4 ROW Advanced Wound Care Product Market Forecast by Value
4.2.5 ROW Advanced Wound Care NPWT Devices Market by Value
4.2.6 ROW Advanced Wound NPWT Devices Market Forecast by Value

Leave a Query @ https://www.wiseguyreports.com/enquiry/3080301-global-advanced-wound-care-market-industry-analysis-outlook-2018-2022

5. Market Dynamics

5.1 Growth Drivers
5.1.1 Rising Ageing Population
5.1.2 Increasing Life Expectancy
5.1.3 Rising Diabetic Population
5.1.4 Escalating Healthcare Spending
5.1.5 Growing Population with Ulcer Pressure
5.1.6 Growing Awareness for Wound Care Products

5.2 Key Trends & Developments
5.2.1 Favorable Reimbursement Policies
5.2.2 New Technological Advancements
5.2.3 Rising Research & Development Activities
5.2.4 Emerging Middle Class Population

5.3 Challenges
5.3.1 High Cost for Advanced Wound Care Products
5.3.2 Stringent Regulatory Approvals

6. Competition

6.1 Global Market
6.1.1 Revenue and Market Cap Comparison
6.1.2 Global Wound Care Market Share by Company
6.1.3 Global Advanced Wound Care- Market Share by Company
6.1.4 Global Advanced Wound NPWT Devices- Market Share by Company
6.1.5 Global Advanced Foam Wound Market Share by Company
6.1.6 Global Advanced Antimicrobials/Silver Market Share by Company

7. Company Profiles

7.1 Coloplast
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies

7.2 ConvaTec
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies

7.3 Smith & Nephew Plc.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies

7.4 Molnlycke
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3080301

Continued…                       

 

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

3D Printing (Additive Manufacturing) Market 2019 Global Analysis, Growth, Size, Share, Trends, Forecast to 2024

3D Printing (Additive Manufacturing) -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024

PUNE, MAHARASHTRA, INDIA, July 31, 2019 /EINPresswire.com/ — 3D Printing (Additive Manufacturing) Industry

Description

3D printing, also known as additive manufacturing, is a process used to build three-dimensional objects by stacking successive layers of raw materials until the object takes the desired form. The deposition of layers are governed by computer-aided software which houses a virtual 3D blueprint as well as technical specifications needed for fabrications, including measurements (length, width and height) of each layer. As per the specifications, CAD slices the virtual model into layers and sends a string of code to the 3D printer on how to stack the layers of raw material. A layer can be as thick as one-thousandth of an inch, thus 3D printing is usually considered to be an extremely high-precision manufacturing procedure. 3D printing is predominantly used for producing functional parts and models/prototypes for various applications within industrial, healthcare, government, defense and consumer end markets.

North America is a major contributor to the global 3D printing market supported by early adoption of 3D printing technologies and technical advancements. Europe also contributed a significant share to the global 3D printing market.

Aerospace and Medical & Dental industries were significant in the global 3D printing market growth due to strong penetration of 3D printed products in these industries. Automotive industry has also made a push to leverage the global 3D printing market.

The global 3D printing market is expected to grow in future due to rapid urbanization, increasing number of 3D printer manufacturers, growing sales of 3D inkjet printheads, increasing number of FDA approved medical products and rising disposable income. Key trends of this market include strengthening ASPs of industrial 3D printers, overcoming the challenges and demand of 3D printing in aerospace and automotive industry. However, there are some factors which can hinder the market growth including intellectual property concerns and 3D printing as a security risk.

The report “Global 3D Printing Market: Industry Analysis & Outlook (2018-2022)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S., Asia-Pacific and Europe region along with the global market. The report profiles the key players of the market including HP Inc., 3D Systems, Stratasys and Materialise NV.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3134077-global-3d-printing-additive-manufacturing-market-industry-analysis

Table of Content

1. Overview

1.1 3D Printing
1.2 Segments of 3D Printing Market
1.3 3D Printing End-Markets

2. Global 3D Printing Market Analysis

2.1 3D Printing Market by Value
2.2 3D Printing Market Value Forecast
2.3 3D Printing Market by Segment
2.3.1 Global 3D Printing Products Market Value Forecast
2.3.2 Global 3D Printing Materials Market Value Forecast
2.3.3 Global 3D Printing Metal Powder Market Value Forecast
2.3.4 Global 3D Printing Parts & Services Market Value Forecast
2.4 3D Printing Market by End Users
2.4.1 Global Industrial 3D Printing Market Value Forecast
2.4.2 Global Aerospace 3D Printing Market Value Forecast
2.4.3 Global Consumer 3D Printing Market Value Forecast
2.4.4 Global Automotive 3D Printing Market Value Forecast
2.4.5 Global Medical/Dental 3D Printing Market Value Forecast
2.5 3D Printing Market by Application
2.6 3D Printing Market by Region

3. Regional Market Analysis

3.1 North America
3.1.1 North America 3D Printing Market Value Forecast

3.2 Europe
3.2.1 Europe 3D Printing Market Value Forecast
3.2.2 Europe 3D Printing Market by Country

3.3 Asia-Pacific
3.3.1 Asia-Pacific 3D Printing Market Value Forecast
3.3.2 Asia-Pacific 3D Printing Market by Country

4. Market Dynamics

4.1 Growth Drivers
4.1.1 Increasing Number of 3D Printer Manufacturers
4.1.2 Growing 3D Inkjet Printhead Sales
4.1.3 Rapid Urbanization
4.1.4 Increasing Disposable Income
4.1.5 Increasing Number of Approved 3D Printed Medical Products by FDA

4.2 Key Trends
4.2.1 ASP of Industrial 3D Printers
4.2.2 Overcoming the Challenges
4.2.3 Demand of 3D Printing in Aerospace and Automotive Industry

4.3 Challenges
4.3.1 Intellectual Property Concerns
4.3.2 3D Printing as Security Risk

5. Competition

5.1 Global Market
5.1.1 Key Players of 3D Printing Market
5.1.2 Market Cap Comparison of Key Players

Leave a Query @ https://www.wiseguyreports.com/enquiry/3134077-global-3d-printing-additive-manufacturing-market-industry-analysis

6. Company Profiles

6.1 HP Inc
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies

6.2 Stratasys Ltd.
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies

6.3 3D Systems
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies

6.4 Materialise
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies

List of Charts

Types of 3D Printing Technologies
3D Printing Market Segments
Global 3D Printing Market by Value (2013-2017)
Global 3D Printing Market Value Forecast (2017-2022)
Global 3D Printing Market by Segment (2017/2022)
Global 3D Printing Products Market Value Forecast (2017-2022)
Global 3D Printing Materials Market Value Forecast (2017-2022)
Global 3D Printing Metal Powder Market Value Forecast (2017-2022)
Global 3D Printing Parts & Services Market Value Forecast (2017-2022)
Global 3D Printing Market by End Users (2017)
Global Industrial 3D Printing Market Value Forecast (2013-2022)
Global Aerospace 3D Printing Market Value Forecast (2013-2022)
Global Consumer 3D Printing Market Value Forecast (2013-2022)
Global Automotive 3D Printing Market Value Forecast (2013-2022)

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2820053

Continued…

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

U.S. Reps. Frank Pallone, Josh Gottheimer Champion Passage of Anti Horse Cruelty Legislation in a Landslide, 333 Votes

Soring

Example of soring that enforcement of the Horse Protection Act would prevent

This bill has received endorsements from hundreds of equine and veterinary organizations, including more than 60 state and national horse groups and all 50-state medical veterinary associations.”

— Chairman Frank Pallone (NJ-06)

WASHINGTON, DC, USA, July 31, 2019 /EINPresswire.com/ — On Thursday, the U.S. House of Representatives passed the Prevent All Soring Tactics (PAST) Act, H.R. 693, by a vote of 333 to 96. U.S. Reps. Frank Pallone, Josh Gottheimer, Chris Smith, Donald Norcross, Jefferson Van Drew, Andy Kim, Tom Malinowski, Albio Sires, Bill Pascrell, Jr., Donald Payne, Jr., Mikie Sherrill, and Bonnie Watson Coleman – the entire House Delegation from New Jersey – voted in support of the measure.

The PAST Act seeks to strengthen the Horse Protection Act and end the torturous, painful practice of soring Tennessee Walking, Racking, and Spotted Saddle Horses. Soring, the intentional infliction of pain to horses' front limbs by applying caustic chemicals such as mustard oil or kerosene or inserting sharp objects into the horses' hooves to create an exaggerated gait known as the "Big Lick,” has plagued the equine world for six decades.

The bill had been blocked for years by a handful of well-placed lawmakers, but a new House rule, championed by Rep. Gottheimer and the House Problem Solvers Caucus that was implemented in January, now triggers consideration of any measure that attracts 290 or more cosponsors brought the issue to the floor. The PAST Act attracted 308 cosponsors and was led by U.S. Reps. Kurt Schrader (D-OR) and Ted Yoho (R-FL), co-chairs of the Congressional Veterinary Medicine Caucus, along with Reps. Steve Cohen (D-TN), Ron Estes (R-KS), Jan Schakowsky (D-IL), and Chris Collins (R-NY). The Senate companion bill is led by U.S. Sens. Mike Crapo (R-ID) and Mark Warner (D-VA) and has garnered 40 cosponsors.

“We applaud the New Jersey House delegation for voting to pass the PAST Act, and we thank Chairman Frank Pallone, and Rep. Gottheimer for their key role in the passage of this bill to end this barbaric and indefensible practice that has marred the horse show world for decades,” said Marty Irby, executive director at Animal Wellness Action and past president of the Tennessee Walking Horse Breeders’ & Exhibitors’ Association. “The entire New Jersey delegation’s support of the bill is a powerful signal to the Senate that it should saddle up and end this cruelty to horses once and for all.”

“This bill has received endorsements from hundreds of equine and veterinary organizations, including more than 60 state and national horse groups and all 50-state medical veterinary associations,” said U.S. House Energy and Commerce Committee Chairman Frank Pallone (NJ-06). “I thank Representative Schrader for his continued leadership and it’s time that Congress pass this legislation and put an end to soring once and for all.”

"New Jersey is home to thousands of companion, show, and sport horses. I believe we need to do all we can to protect horses from cruel practices like soring," said U.S. Rep. Josh Gottheimer (NJ-05) . "That is why I was proud to co-sponsor the bipartisan PAST Act and I commend Congressman Schrader on his leadership combating this issue.”

“Horse soring is a cruel, unethical and illegal practice that has thrived because of lax enforcement for far too long,” said U.S. Rep. Donald Norcross (NJ-01). “Unfortunately, certain horse trainers have taken advantage of the system, failed to self-police and are forcing horses into a lifetime of suffering. As a longtime supporter of animal rights, I know that it’s well-past time we take action and finally end this abuse.”

The PAST Act, under the jurisdiction of the House Committee on Energy and Commerce, chaired by Pallone, would ban the use of painful large stacked shoes and ankle chains and would also eliminate the existing system of self-regulation by the industry and toughen penalties for violators of the Horse Protection Act. It's supported by Animal Wellness Action, the American Horse Council, American Veterinary Medical Association, American Association of Equine Practitioners, United States Equestrian Federation, National Sheriff’s Association, and Tennessee Veterinary Medical Association.

See what Members of Congress from across the nation have to say about the PAST Act by clicking here for our landing page.

The Animal Wellness Foundation (Foundation) is a Los Angeles-based private charitable organization with a mission of helping animals by making veterinary care available to everyone with a pet, regardless of economic ability. We organize rescue efforts and medical services for dogs and cats in need and help homeless pets find a loving caregiver. We are advocates for getting veterinarians to the front lines of the animal welfare movement; promoting responsible pet ownership; and vaccinating animals against infectious diseases such as distemper. We also support policies that prevent animal cruelty and that alleviate suffering. We believe helping animals helps us all.

Animal Wellness Action (Action) is a Washington, D.C.-based 501(c)(4) organization with a mission of helping animals by promoting legal standards forbidding cruelty. We champion causes that alleviate the suffering of companion animals, farm animals, and wildlife. We advocate for policies to stop dogfighting and cockfighting and other forms of malicious cruelty and to confront factory farming and other systemic forms of animal exploitation. To prevent cruelty, we promote enacting good public policies and we work to enforce those policies. To enact good laws, we must elect good lawmakers, and that’s why we remind voters which candidates care about our issues and which ones don’t. We believe helping animals helps us all.

Marty Irby
ANIMAL WELLNESS ACTION
+1 2028215686
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire